28 August 2015

DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/k7pp7t/analysis_of_the) has announced the addition of the "Analysis of the Immunochemistry Market in Malaysia" report to their offering. The Malaysian immunochemistry market is dominated by Roche, Siemens, and Beckman Coulter. Buy Singulair (Montelukast) with no Rx Other participants are Becton Dickenson, Abbott, Sysmex, and some Chinese companies. About Dilantin (Phenytoin) with free Rx The demand for immunochemistry tests in tertiary care hospitals is high. Buy Minomycin (Minocycline) with free prescription Automated equipment is preferred but some tier I and II hospitals operate on semi-automated chemistry analyzers. Enalapril Public hospitals procure equipment using tenders, while reagents are purchased in batches 2-3 times a year. Prometrium (Progesterone) The demand for immunochemistry tests will grow, as communicable disease testing has increased and preventive tests are common. Key Topics Covered: 1. Buy Back Pain Relief online Executive Summary - Scope and Segmentation 2. http://allergy-opinion.blogspot.com Key Trends - Key Companies to Watch - Roche - Key Companies to Watch - Axon Scientific - Key Companies to Watch - BP Healthcare - Key Companies to Watch - Snibe 3. Overview of the Malaysian Healthcare Market - Overview of Healthcare Expenditure in Malaysia - Overview of Population Forecast in Malaysia - Growing Demand for and Affordability of Quality Healthcare Services - Growth in Malaysian Hospitals - Parallel Public and Private Healthcare Sectors in Malaysia - Classification of Healthcare Services (HCS) in Malaysia - Access to Public Secondary and Tertiary Service Care - Principal Cause of Death in Public Hospitals - Principal Cause of Death in Private Hospitals 4. Overview of the Malaysian Hospital Market and Trends in the Immunochemistry Testing Market - Malaysian Hospitals - Market Overview - Category High Public Hospitals (>650 Beds per Hospital) - Key States - Category Medium Public Hospitals (150-650 Beds) - Key States - Category Low Public Hospitals (< 150 Beds) - Key States - Malaysian IVD Market - Market Segmentation - Customer Segmentation in the Malaysian Immunochemistry Market - Segmentation of Key Immunochemistry Tests in Public Hospitals - Type of Tests - Top 3 Immunochemistry Tests in Demand in Malaysian Hospitals - Usage Pattern of Immunochemistry Equipment - In spite of prices of Healthcare services will get impacted due to GST, the volume of test is unlikely to be effected - Demand for Automated Immunochemistry Equipment Versus Conventional End User s Perspective - Procurement Process of Immunochemistry Equipment in Public Hospitals - Procurement Process of Immunochemistry Equipment in Private Hospitals and Diagnostic Laboratories 5. Competitor Playbook - Overview of Key Competitors in the Immunochemistry Market in Malaysia - Revenue Forecast - Demand for Immunochemistry Equipment in Malaysia - A Distributor s Perspective - Top 3 Competitors - Manufacturers - Segment Analysis of Competitors in the Immunochemistry Market - Key Distributors in the Malaysian Immunochemistry Market 6. Opportunities, Drivers, and Restraints in the Malaysian Immunochemistry Market - Opportunity for Automated Equipment Manufacturers - New Public Hospitals in Malaysia - New Private Hospitals in Malaysia - Key Market Drivers - Key Market Restraints 7. Future Trends in the Malaysian Immunochemistry Market For more information visit .researchandmarkets.com/research/k7pp7t/analysis_of_the

No comments:

Post a Comment